Last edition
News about "Virupaksha Organics Files Draft Papers with SEBI f"
Virupaksha Organics Files Draft Papers with SEBI for INR 740 Crore IPO
Virupaksha Organics, an R&D-driven Indian pharmaceutical company specialising in active pharmaceutical ingredients (APIs) and intermediates, has filed draft papers with India’s capital markets regulator, SEBI, to raise INR 740 crore through an initial public offering (IPO).
Virupaksha Organics Files Draft Papers With SEBI F | 01/10/2025 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members